Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

US Patent 8765796 · Granted Jul 1, 2014

Assignee

Inventors

View full patent text on Google Patents →